Loading viewer...
investor_presentation
Format: PDF investor_presentation
Fusion Pharmaceuticals presents its targeted alpha therapy platform for developing next-generation radiopharmaceuticals focused on precision oncology applications. The company showcases its technology approach to creating innovative cancer therapeutics through advanced radiopharmaceutical development.
26 Pages
Fusion Pharmaceuticals Corporate Presentation 2023
investor_presentationinvestor_presentation
37 Pages
investor_presentation
36 Pages
Unknown
Sonoma Pharmaceuticals Investor Presentation April 2024
investor_presentationinvestor_presentation
32 Pages
Sonoma Pharmaceuticals, Inc.